Drug Discovery and Development
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Leap, Merck KGaA, Pfizer Partner for Cancer
Will evaluate Leap’s GITR agonist, TRX518, in combination with avelumab, a human anti-PD-L1 IgG1 monoclonal antibody, & chemo07.23.18
-
Bio News | Drug Discovery | Industry News | Trials & Filings
Rockwell Medical Announces FDA Approval
For Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis07.23.18
-
Collaborations & Alliances | Industry News | Information Technology
Samsung BioLogics Selects Veeva's Vault QualityDocs
To provide transparency into content status and processes for internal and external users, partners, and suppliers worldwide07.23.18
-
The Times, They Are a-Changin’
For contract organizations and generics, for sureEmil W. Ciurczak, DoraMaxx Consulting 07.20.18
-
Bio News | Breaking News | Drug Development | Drug Discovery | Facilities | Industry News | Laboratory Testing | R&D
PolyU, Axis Therapeutics Partner for Immunotherapy
The joint immunotherapy center will aim to conduct collaborative research on cancer immunotherapy in Hong KongVideos
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Galapagos and MorphoSys Partner with Novartis
Novartis will cover development and commercialization costs of their joint program, MOR10607.19.18
-
Industry News | Laboratory Testing | R&D
-
Analytical Services | Industry News
Dalton Adds ICP-MS Capability
Agilent 7800 ICP-MS quadrupole analyzer is currently validated and ready for use07.19.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Kite, Gadeta Enter Collaboration
To develop novel gamma delta TCR therapies in various cancers07.19.18
-
Collaborations & Alliances | Drug Development
-
Bioanalytical Services | cGMP Manufacture | Drug Development | Industry News
Avalon GloboCare Launches Avactis Biosciences Subsidiary
Will focus on accelerating commercial activities related to its (CAR)-T technologies07.19.18
-
Drug Development | Industry News | Process Development
Sterigenics Expands European Capacity
To build new state-of-the-art gamma sterilization facility in the UK07.19.18
-
Clinical Trials | Collaborations & Alliances | Industry News | R&D
Takeda, Ovid Detail Clinical Development Program
The companies plan to initiate three clinical trials to investigate the potential of TAK-935/OV93507.18.18
-
Collaborations & Alliances | Industry News | Methods Development | R&D
Taconic, Cyagen Announce Partnership
To provide access to premium custom model design and generation services07.18.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Innovest Global Launches Biotech Division
With the acquisition of a 20% interest in StemVax Therapeutics, who is currently developing a cancer vaccine therapy07.18.18
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
leon-nanodrugs Supports Takeda in a Feasibility Assessment
Will utilize proprietary MicroJet Reactor nano-technology07.18.18
-
Breaking News | Industry News | Information Technology | Packaging & Tracking | Serialization
SEA Vision Expands Global Presence With €1.5mn Investment
Opening new offices in the U.S., Germany and Russia07.18.18
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Irvine Scientific Introduces NK Cell Expansion Medium for Immunotherapy Applications
The first chemically-defined, animal component-free cell culture medium for natural killer (NK) cells07.18.18
-
Collaborations & Alliances | Formulation Development
Takeda Selects leon-nanodrugs’s MicroJet Reactor for Feasibility
Assessment could potentially lead to the development of an innovative formulation of one of Takeda's pipeline products07.17.18
-
Drug Development | Industry News
Sinovant, Renexxion to Develop and Commercialize Naronapride
Sinovant gains exclusive license for the development and commercialization of naronapride in China07.17.18
